Is DRd an effective treatment for older, non-transplant eligible myeloma patients?

Is DRd an effective treatment for older, non-transplant eligible myeloma patients?

Is Darzalex, Revlimid, and dexamethasone (DRd) a good treatment option for non-transplant eligible myeloma patients?

The BOTTOM LINE: The three-drug combination DRd is an effective treatment for non-transplant eligible myeloma patients.
_______________
Improving Lives | Finding the Cure

In the United States, an estimated 32,270 new multiple myeloma cases will be diagnosed in 2021. 159,985 new myeloma cases are diagnosed yearly.

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.

Subscribe to our channel: https://www.youtube.com/c/IMFMyeloma

Visit our website at: https://www.myeloma.org

Find us online:
Facebook: @myeloma | https://facebook.com/myeloma
Twitter: @IMFMyeloma | https://twitter.com/IMFmyeloma
Instagram: @imfmyeloma | https://www.instagram.com/imfmyeloma
LinkedIn: https://www.linkedin.com/company/international-myeloma-foundation

Support the IMF! http://bit.ly/WskQHC
Category
Nonprofits & Activism
License
Standard YouTube License

In most cases, captions are autogenerated by YouTube.

myelomamultiple myelomacancer

Post a Comment

0 Comments